Mega Genomics Limited (HKG:6667)
Hong Kong
· Delayed Price · Currency is HKD 7.20
-0.05 (-0.69%)
Mar 31, 2025, 3:45 PM HKT
Mega Genomics Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | 31.89 | 30.04 | -17.62 | 79.02 | 79.1 | 29.69 |
| Depreciation & Amortization | 14.57 | 14.97 | 15.12 | 13.77 | 13.94 | 13.99 |
| Other Amortization | 0.16 | 0.16 | 0.16 | 0.11 | 0.09 | 0.07 |
| Loss (Gain) From Sale of Investments | 0.43 | 0.43 | 0.17 | -0.06 | -0.1 | - |
| Stock-Based Compensation | 4.87 | 7.29 | 4.95 | - | - | - |
| Provision & Write-off of Bad Debts | -6.25 | -13.98 | 25.85 | 6.17 | -0.73 | 6.45 |
| Other Operating Activities | -1.3 | -1.62 | -29.47 | 10.13 | 18.66 | 24.47 |
| Change in Accounts Receivable | 29.75 | 82.92 | -7.05 | -79.56 | -21.38 | -20.26 |
| Change in Inventory | 2.04 | -0.9 | -0.22 | -0.31 | -0.53 | 0.54 |
| Change in Accounts Payable | 4.11 | 4.78 | 5.56 | 2.31 | 14.88 | -10.99 |
| Change in Other Net Operating Assets | 31.07 | 39.6 | -4.36 | -0.94 | -1.1 | -6.68 |
| Operating Cash Flow | 111.33 | 163.68 | -6.91 | 30.63 | 102.84 | 37.27 |
| Operating Cash Flow Growth | 26.90% | - | - | -70.22% | 175.91% | - |
| Capital Expenditures | -23.8 | -35.86 | -5.01 | -4.16 | -1.05 | -0.58 |
| Sale of Property, Plant & Equipment | - | - | - | - | - | 0.17 |
| Sale (Purchase) of Intangibles | -0.18 | -0.24 | -0.18 | -0.26 | - | -0.18 |
| Investment in Securities | 12.71 | 2.34 | 2.63 | 2.71 | -30.04 | - |
| Other Investing Activities | - | - | - | - | - | 18.26 |
| Investing Cash Flow | -11.28 | -33.75 | -2.56 | -1.71 | -31.09 | 17.67 |
| Long-Term Debt Issued | - | 23.56 | - | - | - | - |
| Long-Term Debt Repaid | - | -9.35 | -7.32 | -10.59 | -14.09 | -17.23 |
| Net Debt Issued (Repaid) | 10.9 | 14.21 | -7.32 | -10.59 | -14.09 | -17.23 |
| Issuance of Common Stock | - | - | 184.16 | 228.82 | 100 | - |
| Repurchase of Common Stock | -30.87 | -26 | - | -214.14 | - | - |
| Other Financing Activities | -1.79 | -1.12 | -18.38 | -1.47 | -1.85 | -3.05 |
| Financing Cash Flow | -21.76 | -12.91 | 158.46 | 2.62 | 84.06 | -20.28 |
| Foreign Exchange Rate Adjustments | -0.03 | 1.44 | 11.75 | -0.89 | - | - |
| Net Cash Flow | 78.27 | 118.46 | 160.74 | 30.65 | 155.8 | 34.66 |
| Free Cash Flow | 87.53 | 127.83 | -11.92 | 26.47 | 101.79 | 36.69 |
| Free Cash Flow Growth | 23.51% | - | - | -74.00% | 177.43% | - |
| Free Cash Flow Margin | 54.81% | 84.49% | -8.18% | 11.16% | 50.09% | 29.66% |
| Free Cash Flow Per Share | 0.42 | 0.60 | -0.06 | 0.21 | - | - |
| Cash Interest Paid | 1.79 | 1.12 | 0.72 | 0.79 | 1.85 | 3.05 |
| Cash Income Tax Paid | 5.24 | 3.9 | 11.26 | 10.62 | 13.09 | 3.12 |
| Levered Free Cash Flow | 84.46 | 98.11 | 22.72 | -193.51 | 260 | - |
| Unlevered Free Cash Flow | 85.58 | 98.82 | 23.17 | -189.19 | 270.34 | - |
| Change in Net Working Capital | -69.96 | -96.08 | -23.38 | 266.57 | -189.99 | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.